Bank Julius Baer & Co’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bank Julius Baer & Co’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-399	Closed	-$11K	–	882
2021 Q2	$11K	Buy	+399	New	+$7.84K	﹤0.01%	781

Bank Julius Baer & Co's TBIO Position: Q3 2021 in Review

Bank Julius Baer & Co sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 399 shares — an estimated $11K sold.

Bank Julius Baer & Co first reported a position in TBIO in Q2 2021 and held it in 1 quarter. The position peaked at $11K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Bank Julius Baer & Co reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Bank Julius Baer & Co sold 399 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $11K.
Bank Julius Baer & Co first reported a position in Translate Bio, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
Bank Julius Baer & Co's Translate Bio, Inc. Common Stock position peaked at $11K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Bank Julius Baer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.